ArticleCardiovascular diagnosis and therapy2024

Assessing the impact of evolocumab on thin-cap fibroatheroma and endothelial function in patients with very high-risk atherosclerotic cardiovascular disease: a study protocol for a randomized controlled trial.

Bingyu Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.